Emmanuel J Favaloro/LinkedIn
Nov 25, 2025, 08:56
Emmanuel J Favaloro: One of The Main Molecular (Genetic) Tests Used to Diagnose Thrombophilia
Emmanuel J Favaloro, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared a post on LinkedIn:
“A second useful summary table, this one of the main molecular (genetic) tests used to diagnose thrombophilia.. From our recent Editorial ‘Diagnosing thrombophilia: the case for genetic or functional testing?’
Title: Diagnosing thrombophilia: the case for genetic or functional testing?
Authors: Emmanuel J Favaloro, Gary W. Moore, Leonardo Pasalic
Avaible here.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis